胺碘酮用于冠心病急性心肌梗死合并高危快速型心律失常治疗的临床效果分析

Clinical Effect of Amiodarone in the Treatment of Coronary Heart Disease with Acute Myocardial Infarction and High-risk Tachyarrhythmia

探析了胺碘酮用于冠心病急性心肌梗死合并高危快速型心律失常治疗的临床效果。将阳光融和医院于2018年3月-2021年2月收治的41例冠心病急性心肌梗死合并高危快速型心律失常患者作为研究样本,将其分成胺碘酮组(21例)与卡因组(20例)。卡因组患者接受普鲁卡因胺治疗,胺碘酮组患者接受胺碘酮治疗。结果显示,胺碘酮组患者的救治成功率、24h内正常窦性R-R以及射血分数指标高于卡因组,药物毒性反应发生率、心率、NIHSS评分低于卡因组;心律失常纠正时间短于卡因组、左室舒张末期内径与左室收缩末期内径小于卡因组,差异具有统计学意义(P<0.05)o研究表明,对冠心病急性心肌梗死合并高危快速型心律失常患者采取胺碘酮治疗效果理想,适合在临床上推广。

To explore the clinical effect of amiodarone in the treatment of coronary heart disease with acute myocardial inferction and high-risk tachyarrhythmia.41 patients with coronary heart disease and acute myocardial infarction complicated with high-risk tachyarrhythmia admitted by Sunshine Union Hospital from March 2018 to February 2021 were taken as study samples and divided into amiodarone group(21 cases)and cocaine group(20 cases).The patients in the cocaine group were treated with procaine amine,and the patients in the amiodarone group were treated with amiodarone.The results showed that the success rate of treatment,normal sinus R-R and ejection fraction within 24 hours in the amiodarone group were higher than those in the cocaine group,and the incidence of drug toxicity heart rate,arrhythmia correction time,NtHSS score,left ventricular end-diastolic diameter and left ventricular end-systolic diameter were lower than those in the cocaine group,with significant differences(P<0.05).It can be seen that amiodarone treatment for patients with coronary heart disease and acute myocardial infarction complicated with high-risk tachyanhythmia has ideal clinical effect and is suitable for clinical promotion.